Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Walker

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Internal Medicine Journal|June 16, 2010
Survival in scleroderma: results from the population-based South Australian RegisterP Hissaria, S Lester, P Hakendorf, et al.
Scandinavian Journal of Rheumatology|April 14, 2021
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patientsAys Lee, K A Patterson, D J Tan, et al.
Arthritis Research & Therapy|June 25, 2024
The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomesA Quinlivan, D Neuen, D Hansen, et al.
Internal Medicine Journal|September 5, 2015
Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosisA Quinlivan, V Thakkar, W Stevens, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components AnalysisK A Patterson, P J Roberts-Thomson, S Lester, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Internal Medicine Journal|June 16, 2010
Survival in scleroderma: results from the population-based South Australian RegisterP Hissaria, S Lester, P Hakendorf, et al.
Scandinavian Journal of Rheumatology|April 14, 2021
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patientsAys Lee, K A Patterson, D J Tan, et al.
Arthritis Research & Therapy|June 25, 2024
The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomesA Quinlivan, D Neuen, D Hansen, et al.
Internal Medicine Journal|September 5, 2015
Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosisA Quinlivan, V Thakkar, W Stevens, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components AnalysisK A Patterson, P J Roberts-Thomson, S Lester, et al.
Pageof 7